FindTrial
Sign In

Evaluation of the anti-inflammatory effect of continous insulin infusion in non-diabetic patients undergoing cardia surgery - ND

Evaluation of the anti-inflammatory effect of continous insulin infusion in non-diabetic patients undergoing cardia surgery - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-001481-32-IT
Enrollment
Unknown
Registered
2007-03-23
Start date
2006-09-21
Completion date
Unknown
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients candidate to cardiac surgery MedDRA version: 9.1 Level: SOC Classification code 10007541 Term: Cardiac disorders

Interventions

Product Name: Insulin (human) Pharmaceutical Form: Solution for infusion INN or Proposed INN: Insulin (human) Concentration unit: IU international unit(s) Concentration type: equal Concentration num

Sponsors

AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients candidate to cardiac surgery Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Diabetes mellitus BMI 30 kg/m2 Age 75 Infections

Design outcomes

Primary

MeasureTime frame
Main Objective: Evaluation of the effect of continous insulin infusion on the PCR, pro-inflammatory cytokines such as tumor necrosis factor-alfa, IL-1, IL-6 ;Secondary Objective: Evaluation of the effect of continous insulin infusion on the infectious complications in patients undergoing cardia surgery;Primary end point(s): PCR, IL-1, IL-6, TNF-alfa levels—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026